Titre : Vaccins atténués

Vaccins atténués : Questions médicales fréquentes

Termes MeSH sélectionnés :

Intervertebral Disc Displacement

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment savoir si un vaccin est atténué ?

Les vaccins atténués contiennent des agents pathogènes vivants, mais modifiés pour être moins virulents.
Vaccins atténués Agents pathogènes Immunisation
#2

Quels tests pour vérifier l'efficacité d'un vaccin atténué ?

Des tests sérologiques peuvent mesurer la réponse immunitaire après vaccination.
Tests sérologiques Efficacité des vaccins Immunité

Symptômes 2

#1

Quels symptômes peuvent apparaître après un vaccin atténué ?

Des symptômes bénins comme fièvre légère ou douleur au site d'injection peuvent survenir.
Réactions aux vaccins Effets secondaires Fièvre
#2

Les vaccins atténués causent-ils des maladies ?

Rarement, mais ils peuvent provoquer des symptômes légers similaires à la maladie ciblée.
Maladies infectieuses Réactions indésirables Vaccins

Prévention 2

#1

Comment se préparer avant de recevoir un vaccin atténué ?

Informez votre médecin de vos antécédents médicaux et allergies avant la vaccination.
Préparation à la vaccination Antécédents médicaux Vaccins
#2

Les vaccins atténués sont-ils sûrs pour tous ?

Ils ne conviennent pas à certaines personnes, comme celles immunodéprimées.
Immunodépression Sécurité des vaccins Vaccins atténués

Traitements 2

#1

Que faire en cas de réaction sévère à un vaccin atténué ?

Consulter immédiatement un professionnel de santé pour évaluer la situation.
Réactions allergiques Traitement médical Vaccins
#2

Les vaccins atténués nécessitent-ils un traitement préventif ?

Non, mais des antécédents médicaux doivent être évalués avant la vaccination.
Antécédents médicaux Prévention Vaccins

Complications 2

#1

Quelles complications peuvent survenir avec un vaccin atténué ?

Des complications rares incluent des infections chez les personnes immunodéprimées.
Complications Infections Vaccins atténués
#2

Les complications des vaccins atténués sont-elles fréquentes ?

Non, elles sont rares et généralement bénignes, mais nécessitent une surveillance.
Surveillance médicale Effets indésirables Vaccins

Facteurs de risque 2

#1

Qui devrait éviter les vaccins atténués ?

Les personnes immunodéprimées ou enceintes doivent éviter ces vaccins.
Immunodépression Grossesse Vaccins atténués
#2

Les antécédents d'allergies influencent-ils la vaccination ?

Oui, des antécédents d'allergies graves peuvent nécessiter une évaluation préalable.
Allergies Évaluation médicale Vaccins
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Vaccins atténués : Questions médicales les plus fréquentes", "headline": "Vaccins atténués : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Vaccins atténués : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-19", "dateModified": "2025-04-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Vaccins atténués" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Vaccins", "url": "https://questionsmedicales.fr/mesh/D014612", "about": { "@type": "MedicalCondition", "name": "Vaccins", "code": { "@type": "MedicalCode", "code": "D014612", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894" } } }, "about": { "@type": "MedicalCondition", "name": "Vaccins atténués", "alternateName": "Vaccines, Attenuated", "code": { "@type": "MedicalCode", "code": "D014613", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Aitor Nogales", "url": "https://questionsmedicales.fr/author/Aitor%20Nogales", "affiliation": { "@type": "Organization", "name": "Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. aitor_nogales@hotmail.com." } }, { "@type": "Person", "name": "Charles Grose", "url": "https://questionsmedicales.fr/author/Charles%20Grose", "affiliation": { "@type": "Organization", "name": "Department of Pediatrics, Division of Infectious Diseases/Virology Laboratory, University of Iowa, Iowa City, IA 52242, USA." } }, { "@type": "Person", "name": "Manish Patel", "url": "https://questionsmedicales.fr/author/Manish%20Patel", "affiliation": { "@type": "Organization", "name": "Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: aul3@cdc.gov." } }, { "@type": "Person", "name": "Jessie R Chung", "url": "https://questionsmedicales.fr/author/Jessie%20R%20Chung", "affiliation": { "@type": "Organization", "name": "Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia; JChung@cdc.gov." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Macrophages and Intervertebral Disc Degeneration.", "datePublished": "2023-01-10", "url": "https://questionsmedicales.fr/article/36674887", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms24021367" } }, { "@type": "ScholarlyArticle", "name": "Genetics of Intervertebral Disc Degeneration.", "datePublished": "2023-01-21", "url": "https://questionsmedicales.fr/article/36680730", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11914-022-00769-0" } }, { "@type": "ScholarlyArticle", "name": "Effect of DiscoGel treatment of the intervertebral disc at MRI.", "datePublished": "2023-08-15", "url": "https://questionsmedicales.fr/article/37633745", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.crad.2023.07.023" } }, { "@type": "ScholarlyArticle", "name": "Association between intervertebral disc degeneration and Behçet's disease.", "datePublished": "2022-05-23", "url": "https://questionsmedicales.fr/article/35569115", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/dth.15585" } }, { "@type": "ScholarlyArticle", "name": "Cervical Schwannoma camouflaged by cervical intervertebral disc prolapse-A case report.", "datePublished": "2023-10-28", "url": "https://questionsmedicales.fr/article/37898665", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41394-023-00609-y" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Mélanges complexes", "item": "https://questionsmedicales.fr/mesh/D045424" }, { "@type": "ListItem", "position": 3, "name": "Produits biologiques", "item": "https://questionsmedicales.fr/mesh/D001688" }, { "@type": "ListItem", "position": 4, "name": "Vaccins", "item": "https://questionsmedicales.fr/mesh/D014612" }, { "@type": "ListItem", "position": 5, "name": "Vaccins atténués", "item": "https://questionsmedicales.fr/mesh/D014613" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Vaccins atténués - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Vaccins atténués", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Vaccins atténués", "description": "Comment savoir si un vaccin est atténué ?\nQuels tests pour vérifier l'efficacité d'un vaccin atténué ?", "url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Intervertebral+Disc+Displacement#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Vaccins atténués", "description": "Quels symptômes peuvent apparaître après un vaccin atténué ?\nLes vaccins atténués causent-ils des maladies ?", "url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Intervertebral+Disc+Displacement#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Vaccins atténués", "description": "Comment se préparer avant de recevoir un vaccin atténué ?\nLes vaccins atténués sont-ils sûrs pour tous ?", "url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Intervertebral+Disc+Displacement#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Vaccins atténués", "description": "Que faire en cas de réaction sévère à un vaccin atténué ?\nLes vaccins atténués nécessitent-ils un traitement préventif ?", "url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Intervertebral+Disc+Displacement#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Vaccins atténués", "description": "Quelles complications peuvent survenir avec un vaccin atténué ?\nLes complications des vaccins atténués sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Intervertebral+Disc+Displacement#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Vaccins atténués", "description": "Qui devrait éviter les vaccins atténués ?\nLes antécédents d'allergies influencent-ils la vaccination ?", "url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Intervertebral+Disc+Displacement#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment savoir si un vaccin est atténué ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccins atténués contiennent des agents pathogènes vivants, mais modifiés pour être moins virulents." } }, { "@type": "Question", "name": "Quels tests pour vérifier l'efficacité d'un vaccin atténué ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sérologiques peuvent mesurer la réponse immunitaire après vaccination." } }, { "@type": "Question", "name": "Quels symptômes peuvent apparaître après un vaccin atténué ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes bénins comme fièvre légère ou douleur au site d'injection peuvent survenir." } }, { "@type": "Question", "name": "Les vaccins atténués causent-ils des maladies ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Rarement, mais ils peuvent provoquer des symptômes légers similaires à la maladie ciblée." } }, { "@type": "Question", "name": "Comment se préparer avant de recevoir un vaccin atténué ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Informez votre médecin de vos antécédents médicaux et allergies avant la vaccination." } }, { "@type": "Question", "name": "Les vaccins atténués sont-ils sûrs pour tous ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Ils ne conviennent pas à certaines personnes, comme celles immunodéprimées." } }, { "@type": "Question", "name": "Que faire en cas de réaction sévère à un vaccin atténué ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Consulter immédiatement un professionnel de santé pour évaluer la situation." } }, { "@type": "Question", "name": "Les vaccins atténués nécessitent-ils un traitement préventif ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Non, mais des antécédents médicaux doivent être évalués avant la vaccination." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec un vaccin atténué ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des complications rares incluent des infections chez les personnes immunodéprimées." } }, { "@type": "Question", "name": "Les complications des vaccins atténués sont-elles fréquentes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles sont rares et généralement bénignes, mais nécessitent une surveillance." } }, { "@type": "Question", "name": "Qui devrait éviter les vaccins atténués ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes immunodéprimées ou enceintes doivent éviter ces vaccins." } }, { "@type": "Question", "name": "Les antécédents d'allergies influencent-ils la vaccination ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents d'allergies graves peuvent nécessiter une évaluation préalable." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 13/04/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

None None

3 publications dans cette catégorie

Publications dans "Vaccins atténués" :

Aitor Nogales

3 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. aitor_nogales@hotmail.com.

Charles Grose

2 publications dans cette catégorie

Affiliations :
  • Department of Pediatrics, Division of Infectious Diseases/Virology Laboratory, University of Iowa, Iowa City, IA 52242, USA.

Manish Patel

2 publications dans cette catégorie

Affiliations :
  • Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: aul3@cdc.gov.

Jessie R Chung

2 publications dans cette catégorie

Affiliations :
  • Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia; JChung@cdc.gov.

Brendan Flannery

2 publications dans cette catégorie

Affiliations :
  • Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.

Ashley L Fowlkes

2 publications dans cette catégorie

Affiliations :
  • Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :

Alicia M Fry

2 publications dans cette catégorie

Affiliations :
  • Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :

James Weger-Lucarelli

2 publications dans cette catégorie

Affiliations :
  • Department of Biomedical Sciences and Pathobiology, Virginia Tech, VA-MD Regional College of Veterinary Medicine, Blacksburg, VA, USA. weger@vt.edu.
  • Center for Emerging, Zoonotic, and Arthropod-borne Pathogens, Virginia Tech, Blacksburg, VA, USA. weger@vt.edu.

Anne A Gershon

2 publications dans cette catégorie

Affiliations :
  • Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.

Michael D Gershon

2 publications dans cette catégorie

Affiliations :
  • Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.

Pilar Blanco-Lobo

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. piblanlo@gmail.com.

Luis Martínez-Sobrido

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. luis_martinez@urmc.rochester.edu.

Stephen Higgs

2 publications dans cette catégorie

Affiliations :
  • Biosecurity Research Institute, Kansas State University, Manhattan, Kansas, USA.

Laura Rodriguez

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochestergrid.16416.34, Rochester, New York, USA.
  • Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.

Michael E Smith

2 publications dans cette catégorie

Affiliations :
  • Baylor Scott & White Health, Temple, TX, United States.

Kayan Dunnigan

2 publications dans cette catégorie

Affiliations :
  • Baylor Scott & White Health, Temple, TX, United States.

Manjusha Gaglani

2 publications dans cette catégorie

Affiliations :
  • Baylor Scott & White Health, Temple, TX, United States; Texas A&M University College of Medicine, Temple, TX, United States.

Mark G Thompson

2 publications dans cette catégorie

Affiliations :
  • U.S. Centers for Disease Control and Prevention, Influenza Division, Atlanta, GA, United States.

Luis Martinez-Sobrido

2 publications dans cette catégorie

Affiliations :
  • Texas Biomedical Research Institute, San Antonio, TX, USA. Electronic address: lmartinez@txbiomed.org.

Sources (4719 au total)

Genetics of Intervertebral Disc Degeneration.

Intervertebral disc degeneration is a contributor to chronic back pain. While a part of the natural aging process, early or rapid intervertebral disc degeneration is highly heritable. In this review, ... Use of large cohorts of patient data to conduct genome-wide association studies (GWAS) for intervertebral disc disease, and to lesser extent for aspects of this process, such as disc height, has resul...

Effect of DiscoGel treatment of the intervertebral disc at MRI.

To determine the impact of ethanol gel chemonucleolysis (EGCh) on the radiological picture of the treated intervertebral disc, the relationship between the initial radiological status and the clinical... The study involved a group of 45 patients (25 men and 20 women) aged 23-68 years (46 ± 11) who underwent an EGCh procedure after qualification, radiography, and clinical questionnaire evaluation.... The results showed a decrease in the size of the protrusion and Gadolinium-Enhanced (GI) zone in the treated intervertebral disc. The presence of a high-intensity zone (HIZ) on baseline magnetic reson... These findings suggest that EGCh is a promising treatment for spine diseases, and the HIZ on baseline magnetic resonance imaging can be used as a qualification criterion for this procedure....

Cervical Schwannoma camouflaged by cervical intervertebral disc prolapse-A case report.

Cervical prolapsed intervertebral disc is one of the common conditions causing cervical myeloradiculopathy. Anterior Cervical Discectomy and Fusion (ACDF) is the standard line of management for the sa... We report a patient with C5-6 cervical disc prolapse that presented with radiculopathy symptoms in the right upper limb, which was refractory to conservative care. He underwent a C5-6 ACDF and reporte... Careful review of preoperative imaging and contrast MRI study may help in diagnosing cystic schwannomas with concomitant cervical disc herniations that have cord signal changes....

Is conservative treatment a good choice for pediatric intervertebral disc calcification in children?

Paediatric intervertebral disc calcification (PIDC) is a rare disease, and its aetiology remains unknown. This study aimed to analyse the characteristics and clinical outcomes of patients with PIDC.... After applying the exclusion and inclusion criteria, 159 children diagnosed with PIDC were analysed at our hospital between January 2010 and November 2020. Patients' demographic and clinical data were... One hundred and fifty-nine patients were ultimately followed up with for about 12.5 ± 5.8 months. There were 103 male and 56 female, with an average age of 6.08 ± 2.62 years (2 months to 12 years). A ... PIDC can be treated conservatively, even when accompanied by herniation, longitudinal ligament calcification, or clinical neck symptoms.... IV....

Study on the process of intervertebral disc disease by the theory of continuum damage mechanics.

Recently, more and more people suffer from low back pain triggered by lumbar degenerative disc disease. The mechanical factor is one of the most significant causes of disc degeneration. This study aim... A finite element model of the L4-L5 lumbar spine was developed and validated. The model not only considered changes in permeability coefficient with strain, but also included physiological factors suc... The simulation results revealed that the facet joints shared massive stresses of the intervertebral discs, and prevented excessive lumbar spine movement. However, their asymmetrical position may have ... The variation in the biomechanical performance of the intervertebral disc could be attributed to the periodic movement of internal fluids. This study might be helpful for understanding the mechanism o...

Why Are Some Intervertebral Discs More Prone to Degeneration?: Insights Into Isolated Thoracic "Dysgeneration".

Prospective observational study.... To determine the prevalence of isolated thoracic degeneration on magnetic resonance imaging (MRI), demographic factors and imaging features, as well as the patient-reported quality of life outcomes as... Thoracic intervertebral discs are least susceptible to disc degeneration (DD) and may represent a manifestation of "dysgeneration." These discs may never be hydrated from the beginning and seem hypoin... A population-based MRI study of 2007 volunteers was conducted. Each disc from C2/3 to L5/S1 was measured by Pfirrmann and Schneiderman grading. Disc herniation, Schmorl node (SN), high-intensity zones... The mean age of the subjects was 50.0 ± 0.5 and 61.4% were females (n = 1232). Isolated thoracic degeneration was identified in 2.3% of the cohort. Factors associated with isolated thoracic degenerati... Isolated thoracic degeneration demonstrated an earlier age of onset, mostly involving the mid-thoracic region (T5/6-T8/9), and in association with findings such as SN. Subjects with tandem thoracolumb... 1....